Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Palonosetron + Aprepitant + Dexamethasone for Prevention of HEC-Induced Nausea and Vomiting
2005-002641-39Phase 4Completed
- Sponsor
- Helsinn
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of palonosetron, aprepitant and dexamethasone in chemotherapy-induced nausea and vomiting (CINV), sponsored by Helsinn. Primary endpoint: Efficacy in prevention of nausea and vomiting. Started Oct 2005; status: completed.
02
Drugs
palonosetronaprepitantdexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2005-002641-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002641-39.